Omniscient Neurotechnology
Sydney
About Omniscient Neurotechnology
Omniscient Neurotechnology (o8t™) is a pioneering brain mapping company that is revolutionizing brain care with data. Using innovations in medical imaging and machine learning, Omniscient builds applications capable of mapping and analyzing “brain networks” which are formed by the electrical connections within a person’s brain. Such insights are illuminating the neural processes that make us human and helping clinicians and researchers understand, diagnose, and treat complex neurological and mental illnesses. Omniscient is a leader in the field of “connectomics” – the study of the brain’s connections. It recently launched Quicktome™, the world’s first medical device to harness this vital data for neurological care, providing neurosurgeons brain network information prior to life-changing surgery. The company is headquartered in Sydney, Australia with offices globally. For more information, please visit www.o8t.com.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $57.2M
- Funding stage: Late Stage Venture
- Last round: Series D (Jan 2026)
- Website: o8t.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Bioinformatics, Health Care, Machine Learning, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/omniscient-neurotechnology-103306 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.